EUVIMEDEUVIMED entdecken
Crossref

The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

Zekeriya Hannarici iD, Ali Yılmaz iD, Mehmet Emin Buyukbayram, Aykut Turhan, Alperen Akansel Çağlar, Mehmet Bilici, Salim Başol Tekin

Future Oncology · 2023-02 · 19 (4) · 315-325

DOI: 10.2217/fon-2022-0579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Oncology, online erschienen am 09.03.2023. Verfasst von Zekeriya Hannarici und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, 25100, Turkey. Hauptthemen laut MEDLINE: Glucose, Stomach Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To demonstrate the prognostic importance of glucose-to-lymphocyte ratio (GLR) in metastatic gastric cancer (mGC).

Methods

Retrospectively, 159 mGC patients were enrolled. Kaplan-Meier curve and Cox regression analysis were used to determine the prognostic value of the systemic immune inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), prognostic nutritional index (PNI) and GLR.

Results

Progression-free survival (PFS) and overall survival (OS) were associated with NLR, PNI, SII and GLR by univariate analysis. Moreover, OS was associated with Eastern Cooperative Oncology Group performance status and the chemotherapy regimen. In multivariate analysis, only GLR was found to be independently prognostic for both PFS and OS.

Conclusion

In mGC, GLR may be a new prognostic marker for both OS and PFS. Gastric cancer (GC) is the fourth cause of cancer-related deaths. Although different treatment algorithms, including immunotherapy, are applied in patients with unresectable or disseminated (metastatic) GC (mGC), survival results are not yet at the desired level. Different markers are being investigated to measure the response of cancer to treatment in these patients. Many studies have been conducted in this direction with the thought that the prognosis of these cancers will be affected by the patient's own immune response and nutritional status. Despite this, standard markers have not been established to predict cancer-related survival. Studies have shown a relationship between GC and glucose metabolism processes. Recently, a fasting blood glucose-to-lymphocyte count ratio (GLR) marker was developed that simultaneously evaluates both glucose metabolism and the patient's immune response. GLR was found to be effective in predicting survival time in cancers such as gallbladder cancer and hepatocellular carcinoma. However, the effect of GLR on survival in mGC is unclear. In this study, the authors investigated the prognostic significance of GLR in mGC. They found that low GLR was associated with longer survival in mGC. GLR may be a prognostic marker for survival in patients with mGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucoseStomach NeoplasmsHumansLymphocyte CountRetrospective StudiesLymphocytesPrognosisInflammationNeutrophils

Stichwörter der Autor:innen

gastric cancerglucoselymphocyteprognosis

Substanzen

Glucose

Autor:innen und Institutionen

  • Department of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, 25100, Turkey.
  • Department of Medical Oncology, Health Sciences University Mehmet Akif İnan Training & Research Hospital, Şanlıurfa, 63040, Turkey.

ORCID-Profile: Zekeriya Hannarici, Ali Yılmaz

Zitieren

APA

Hannarici, Z., Yılmaz, A., Buyukbayram, M. E., Turhan, A., Çağlar, A. A., Bilici, M., & Tekin, S. B. (2023). The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Future Oncology, 19(4), 315-325. https://doi.org/10.2217/fon-2022-0579

Vancouver

Hannarici Z, Yılmaz A, Buyukbayram ME, Turhan A, Çağlar AA, Bilici M, et al. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Future Oncology. 2023;19(4):315-325. doi:10.2217/fon-2022-0579

BibTeX
@article{Hannarici2023,
  author = {Hannarici, Zekeriya and Yılmaz, Ali and Buyukbayram, Mehmet Emin and Turhan, Aykut and Çağlar, Alperen Akansel and Bilici, Mehmet and Tekin, Salim Başol},
  title = {The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer},
  journal = {Future Oncology},
  year = {2023},
  volume = {19},
  number = {4},
  pages = {315--325},
  doi = {10.2217/fon-2022-0579}
}
Kostenlos starten →